Different Cardiac Allograft Vasculopathy Progression is Observed Among Three Vessels After Heart Transplantation

被引：0
|
作者：
Ichibori, Yasuhiro
Kotani, Jun-Ichi
Tsukamoto, Yasumasa
Ohtani, Tomohito
Yamaguchi, Osamu
Tachibana, Koichi
Toda, Koichi
Fukushima, Norihide
Sawa, Yoshiki
Sakata, Yasushi
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Transplantation; Vulnerable plaque; Coronary artery disease; Atherosclerosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11590
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Cardiac allograft vasculopathy after heart transplantation: Risk factors and management
    Valantine, H
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (05): : S187 - S193
  • [22] The Role of Cardiac Rehabilitation after Heart Transplantation in the Reduction of Cardiac Allograft Vasculopathy.
    Kittleson, M.
    Patel, J.
    Rafiei, M.
    Osborne, A.
    Chang, D.
    Czer, L.
    Kobashigawa, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 452 - 452
  • [23] Coronary Vasospasm Following Heart Transplantation: Rapid Progression to Aggressive Cardiac Allograft Vasculopathy
    Bertic, Mia
    Chue, Colin Dominic
    Virani, Sean
    Davis, Margot K.
    Ignaszewski, Andrew
    Sedlak, Tara
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (12) : 1687.e9 - 1687.e11
  • [24] LONG-TERM EFFECTS OF ASPIRIN ON CARDIAC ALLOGRAFT VASCULOPATHY PROGRESSION AND ADVERSE OUTCOMES AFTER HEART TRANSPLANTATION
    Asleh, Rabea
    Briasoulis, Alexandros
    Lerman, Amir
    Smith, Byron
    Lopez, Camden
    Pereira, Naveen
    Edwards, Brooks
    Stulak, John
    Kremers, Walter
    Clavell, Alfredo
    Daly, Richard
    Kushwaha, Sudhir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1074 - 1074
  • [25] Cardiac allograft vasculopathy (CAV) is different in CMV high-risk patients after heart transplantation
    Oberndorfer, T. H.
    Frick, M.
    Mussner-Seeber, C. H.
    Hoefer, D.
    Antretter, H.
    Poelzl, G.
    EUROPEAN HEART JOURNAL, 2009, 30 : 388 - 388
  • [26] BENEFIT OF TACROLIMUS/MYCOPHENOLATE TO REDUCE CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Aaronson, Alistair
    Kittleson, Michelle
    Patel, Jignesh
    Rafiei, Matthew
    Osborne, Ashley
    Chang, David
    Czer, Lawrence
    Kobashigawa, Jon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E798 - E798
  • [27] IDENTIFICATION AND DETERMINANTS OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) TRAJECTORIES AFTER HEART TRANSPLANTATION
    Bonnet, Guillaume
    Coutance, Guillaume
    Racape, Maud
    Raynaud, Marc
    van Keer, Jan
    Bories, Marie-Cecile
    Varnous, Shaida
    Rouvier, Philippe
    Guillemain, Romain
    Lecuyer, Lucien
    Bruneval, Patrick
    Duong-Van-Huyen, Jean-Paul
    Taupin, Jean-Luc
    Naesens, Maarten
    Lefaucheur, Carmen
    Jouven, Xavier
    Kobashigawa, Jon
    Loupy, Alexandre
    TRANSPLANT INTERNATIONAL, 2019, 32 : 391 - 391
  • [28] Changes in Myocardial Microvascularisation After Heart Transplantation and During Cardiac Allograft Vasculopathy
    Huibers, M.
    van Pijpen, E.
    Kirkels, H.
    de Jonge, N.
    Vink, A.
    de Weger, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S136 - S136
  • [29] Transforming growth factor β in relation to cardiac allograft vasculopathy after heart transplantation
    Aziz, T
    Hasleton, P
    Hann, AW
    Yonan, N
    Deiraniya, A
    Hutchinson, IV
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (04): : 700 - 707
  • [30] Uric Acid is an Independent Predictor of Cardiac Allograft Vasculopathy After Heart Transplantation
    Asleh, Rabea
    Prasad, Megha
    Briasoulis, Alexandros
    Boilson, Barry A.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Pereira, Naveen L.
    Adigun, Rosalyn
    Simon, Maltais
    Daly, Richard C.
    Lerman, Amir
    Kushwaha, Sudhir S.
    CIRCULATION, 2017, 136
12345